Immatics N.V. (IMTX) stock
IMTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$6.29+0.12 (+1.94%)
Close on Nov 17, 2026Market cap $843.31MP/E –Yield –
Immatics total assets
Total assets on the balance sheet at the end of each period.
Immatics's total assets was €485.74M at Jun 30, 2026. For fiscal 2025 it was €562.34M, down 19.2% from the year before. The highest annual figure on record is €696.15M in fiscal 2024.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | €562.34M | -19.2% |
| FY2024 | Dec 31, 2024 | €696.15M | +36.5% |
| FY2023 | Dec 31, 2023 | €509.97M | +25.0% |
| FY2022 | Dec 31, 2022 | €407.82M | +133.5% |
| FY2021 | Dec 31, 2021 | €174.65M | -31.4% |
| FY2020 | Dec 31, 2020 | €254.65M | +89.6% |
| FY2019 | Dec 31, 2019 | €134.28M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | €485.74M | -15.9% |
| Q4 FY2025 | Dec 31, 2025 | €562.34M | -10.3% |
| Q2 FY2025 | Jun 30, 2025 | €567.30M | -13.1% |
| Q4 FY2024 | Dec 31, 2024 | €696.15M | +36.5% |
| Q3 FY2024 | Sep 30, 2024 | €577.23M | +40.7% |
| Q2 FY2024 | Jun 30, 2024 | €626.97M | +53.7% |
| Q1 FY2024 | Mar 31, 2024 | €653.13M | +77.3% |
| Q4 FY2023 | Dec 31, 2023 | €509.97M | +192.0% |
| Q2 FY2023 | Jun 30, 2023 | €410.19M | +89.5% |
| Q4 FY2022 | Dec 31, 2022 | €407.82M | +60.2% |
| Q2 FY2022 | Jun 30, 2022 | €368.30M | +174.3% |
| Q4 FY2021 | Dec 31, 2021 | €174.65M | – |
| Q2 FY2021 | Jun 30, 2021 | €216.51M | – |
| Q4 FY2020 | Dec 31, 2020 | €254.65M | – |
| Q4 FY2019 | Dec 31, 2019 | €134.28M | – |
See a number that looks wrong?